Per Hedman is head of Cirio’s sector group Life Science, Healthcare and Food.
Per’s practice focuses on businesses that have a significant reliance on IPR, and primarily the life science and health sector (being biotech, pharma, Medtech, e-health, wellness and foods, as well as healthcare and elderly care).
The Biological team’s clients range from early-stage startups to larger public companies, and include also venture and PE funds investing in the life science and health sector.
Per advises companies in all aspects of their business and legal affairs, including regulatory advice, R&D arrangements (such as non-disclosure, material transfer, clinical trial and joint development agreements), commercial relationships (such as manufacturing, supply and distribution agreements), M&A (such as product acquisitions and spin-outs, domestic and cross border), capital-raising transactions (debt and equity), and IPO:s and other capital market transactions.
Per is regularly invited to speak at conferences and seminars on Life Science and health topics.
Per was previously the president of the Corporate and Joint M&A Commission of AIJA (International Association of Young Lawyers).
Swedish and English